This study provides additional in silico evidence of IDH overexpression in GBM, which did not appear to be related to copy number gains and was comparatively higher in GBM IDH-wildtype compared to Grade IV Astrocytoma IDH-mutant. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).